Skip to main content
Premium Trial:

Request an Annual Quote

Pyrosequencing Sells High-Throughput Genotyping System to Oxagen

hNEW YORK, Aug 9 – Pyrosequencing of Uppsala, Sweden said Thursday it had sold a high-throughput PTP genotyping system to Oxagen, a British genomics company.

The deal is the second one between the two companies. Several months ago, Oxagen purchased Pyrosequencing’s PSQ 96 System, a moderate-throughput genotyping system. 

The PTP system is an automated system that uses robotics for sample preparation and contains 384-wellplates. The system is able to score up to 100,000 SNPs per day, Pyrosequencing said. 

Oxagen is conducting family studies as a way of gaining insight into genetic variation. 

"PTP should enable us to scale- up our SNP genotyping capacity based on a proven technology and to reach results at greater speed and lower cost without loss of quality,” Trevor Nicholls, CEO of Oxagen, said in a statement. 

Pyrosequencing said it has so far sold more than 100 of systems to customers around the world.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.